168 related articles for article (PubMed ID: 21325775)
1. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
[TBL] [Abstract][Full Text] [Related]
2. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X
Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082
[TBL] [Abstract][Full Text] [Related]
3. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
Saito T; Matsunaga A
J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
[No Abstract] [Full Text] [Related]
4. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
5. Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg-->Cys) from a patient with lipoprotein glomerulopathy.
Murano T; Matsumura R; Misawa Y; Ozaki H; Miyashita Y; Yoshida S; Sueioshi M; Sugiyama T; Shirai K
Metabolism; 2002 Feb; 51(2):201-5. PubMed ID: 11833049
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
[TBL] [Abstract][Full Text] [Related]
7. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H; Yang Y; Hu Z
J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N
J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
Han HL; Lin S; Sun LS; Zhang P; Zhai DP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
[TBL] [Abstract][Full Text] [Related]
10. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
[TBL] [Abstract][Full Text] [Related]
12. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Xie W; Xie Y; Lin Z; Xu X; Zhang Y
Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
[TBL] [Abstract][Full Text] [Related]
13. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
[TBL] [Abstract][Full Text] [Related]
15. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
[TBL] [Abstract][Full Text] [Related]
16. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
[TBL] [Abstract][Full Text] [Related]
17. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
Saito T; Matsunaga A; Oikawa S
Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
[TBL] [Abstract][Full Text] [Related]
18. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
